Overview
My clinical and research interests center on the development and use of disease-modifying treatments for Alzheimer's disease and related dementias (ADRD). I am a regional leader in the use of amyloid targeted therapies (ATT), including lecanemab and donanemab, for the treatment of early Alzheimer's disease. I serve as director of the Duke Memory Disorders Clinic.
Current Appointments & Affiliations
Assistant Professor of Medicine
·
2020 - Present
Medicine, Geriatrics and Palliative Care,
Medicine
Assistant Professor in Neurology
·
2022 - Present
Neurology, Behavioral Neurology,
Neurology
Senior Fellow of the Center for the Study of Aging and Human Development
·
2020 - Present
Center for the Study of Aging and Human Development,
Institutes and Centers
Education, Training & Certifications
Eastern Virginia Medical School ·
2013
M.D.